FDA Adverse Event Injury Summary report: N

ANCURE ENDOGRAFT (FORMERLY EVT ENDOGRAFT)

MDR report key: 2926139 · Received January 17, 2013

Report

Report Number
2954310-2012-81817
Event Type
Injury
Date Received
January 17, 2013
Date of Event
January 1, 1999
Report Date
December 20, 2012
Manufacturer
GUIDANT ENDOVASCULAR SOLUTIONS
Product Code
MIH
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ATTEMPTS TO OBTAIN ADD'L INFO AND CLARIFICATION REGARDING THE CLINICAL OBSERVATIONS MENTIONED AND INVOLVEMENT OF THE ANCURE PRODUCT FROM THE ARTICLE AUTHOR(S) WERE UNSUCCESSFUL. THE FINDINGS OF THE STUDY WERE SUMMARIZED IN THE ARTICLE: M.T. VOUTE, F.M. BASTOS GONCALVES, J.M. HENDRIKS, R. METZ, M.R.H.M. VAN SAMBEEK, B.E. MUHS, H.J.M. VERHAGEN. "TREATMENT OF POST-IMPLANTATION ANEURYSM GROWTH BY LAPAROSCOPIC SAC FENESTRATION: LONG-TERM RESULTS" EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY; 2012: 44; 40-44.

Description of Event or Problem · 1

BOSTON SCIENTIFIC (FORMERLY GUIDANT) RECEIVED INFO VIA A REVIEW OF THE LITERATURE, A STUDY PERFORMED THAT DISCUSSED LONG TERM RESULTS OF TREATMENT OF POST-IMPLANTATION ANEURYSM GROWTH BY LAPAROSCOPIC SAC FENESTRATION. IN THIS STUDY, ONE PT WAS IDENTIFIED THAT WAS IMPLANTED WITH AN ANCURE ENDOGRAFT DEVICE 6.3 YEARS PRIOR. IT WAS NOTED THAT A TYPE II ENDOLEAK WAS OBSERVED WITH NO ANEURYSM GROWTH REPORTED. THE PT'S DISEASE AND PROGRESSED AND LED TO DILATATION OF A COMMON ILIAC ARTERY. THE LEAK WAS TREATED WITH AN ILIAC EXTENSION. NO ADVERSE PT EFFECTS WERE REPORTED AS A RESULT OF THE ADD'L PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
25548 ANCURE ENDOGRAFT (FORMERLY EVT ENDOGRAFT) GRAFT MIH GUIDANT ENDOVASCULAR SOLUTIONS NA

Patients

Seq Age Sex Outcome Treatment
1 NA Hospitalization| L| R